These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 26400460

  • 1. SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma.
    Brown AL, Lupo PJ, Okcu MF, Lau CC, Rednam S, Scheurer ME.
    Cancer Med; 2015 Nov; 4(11):1679-86. PubMed ID: 26400460
    [Abstract] [Full Text] [Related]

  • 2. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
    Bass JK, Huang J, Onar-Thomas A, Chang KW, Bhagat SP, Chintagumpala M, Bartels U, Gururangan S, Hassall T, Heath JA, McCowage G, Cohn RJ, Fisher MJ, Robinson G, Broniscer A, Gajjar A, Gurney JG.
    Pediatr Blood Cancer; 2014 Apr; 61(4):601-5. PubMed ID: 24504791
    [Abstract] [Full Text] [Related]

  • 3. Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma.
    Rednam S, Scheurer ME, Adesina A, Lau CC, Okcu MF.
    Pediatr Blood Cancer; 2013 Apr; 60(4):593-8. PubMed ID: 23065688
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
    Langer T, Clemens E, Broer L, Maier L, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Mayer B, von dem Knesebeck A, Byrne J, van Dulmen-den Broeder E, Crocco M, Grabow D, Kaatsch P, Kaiser M, Spix C, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Bielack S, Sorg B, Hecker-Nolting S, Kuehni CE, Ansari M, Kompis M, van der Pal H, Parfitt R, Deuster D, Matulat P, Tillmanns A, Tissing WJE, Beck JD, Elsner S, Am Zehnhoff-Dinnesen A, van den Heuvel-Eibrink MM, Zolk O, PanCareLIFE consortium.
    Eur J Cancer; 2020 Oct; 138():212-224. PubMed ID: 32905960
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.
    Barahmani N, Carpentieri S, Li XN, Wang T, Cao Y, Howe L, Kilburn L, Chintagumpala M, Lau C, Okcu MF.
    Neuro Oncol; 2009 Jun; 11(3):292-300. PubMed ID: 18952980
    [Abstract] [Full Text] [Related]

  • 8. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
    Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC.
    Cancer; 2004 Dec 15; 101(12):2802-8. PubMed ID: 15534883
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma.
    Gurney JG, Bass JK, Onar-Thomas A, Huang J, Chintagumpala M, Bouffet E, Hassall T, Gururangan S, Heath JA, Kellie S, Cohn R, Fisher MJ, Panandiker AP, Merchant TE, Srinivasan A, Wetmore C, Qaddoumi I, Stewart CF, Armstrong GT, Broniscer A, Gajjar A.
    Neuro Oncol; 2014 Jun 15; 16(6):848-55. PubMed ID: 24414535
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association between manganese superoxide dismutase polymorphism and risk of lung cancer.
    Zejnilovic J, Akev N, Yilmaz H, Isbir T.
    Cancer Genet Cytogenet; 2009 Feb 15; 189(1):1-4. PubMed ID: 19167605
    [Abstract] [Full Text] [Related]

  • 12. A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population.
    Wu T, Bai H, Zhao Z, Wang M, Hu X, Jiao L, Wu Q, Liu T, Zhang C, Chen H, Zhang J, Song J, Wu L, Zhou W, Tong C, Ying B.
    J Gene Med; 2019 Oct 15; 21(10):e3121. PubMed ID: 31415712
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
    Peleva E, Emami N, Alzahrani M, Bezdjian A, Gurberg J, Carret AS, Daniel SJ.
    Pediatr Blood Cancer; 2014 Nov 15; 61(11):2012-7. PubMed ID: 24976616
    [Abstract] [Full Text] [Related]

  • 20. The genetic vulnerability to cisplatin ototoxicity: a systematic review.
    Tserga E, Nandwani T, Edvall NK, Bulla J, Patel P, Canlon B, Cederroth CR, Baguley DM.
    Sci Rep; 2019 Mar 05; 9(1):3455. PubMed ID: 30837596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.